Skip to content

Clareon CNW0T4 (UDI 00380652410090)Recalls & reported problems

Alcon Laboratories, Inc. · CLAREON BLF TORIC · Class 3 · Implant

All models of Clareon (1142)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00380652410090), received between Apr 10, 2023 and Feb 5, 2026 — classified as 4 injuries, 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Break1

Patient problems

  • Blurred Vision4
  • Visual Impairment2
  • Endophthalmitis1
  • No Clinical Signs, Symptoms or Conditions1
  • Toxic Anterior Segment Syndrome (TASS)1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 5, 2026Adverse Event Without Identified Device or Use Problem

    ADDITIONAL INFORMATION RECEIVED AND REPORTED THAT THE IOL WAS EXCHANGED FOR THE SAME LENS MODEL BUT 4 DIOPTER MORE POWER INDICATING THE CORRECT LENS POWER WAS NOT IMPLANTED INITIALLY. THERE IS NO REPORTED DEFECT OR FAULT WITH THE IOL.

    Patient problems: Blurred Vision; Visual Impairment

    MAUDE report 24267713 ↗
  • MalfunctionJan 13, 2026Break

    A HEALTH CARE PROFESSIONAL REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, IT WAS NOTED THAT THE LENS HAPTIC BROKEN DURING IOL IMPLANTATION. THERE WAS NO PATIENT CONTACT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24050868 ↗
  • InjuryAug 8, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT WANTED TO SWITCH TO DIFFERENT MODEL COMPANY LENS FOR READING. THE IOL WAS EXCHANGED FOR ADVANCED TECHNOLOGY INTRAOCULAR LENSES (ATIOL) MODEL 2 MONTHS 8 DAYS FOLLOWING THE INITIAL IMPLANT PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision

    MAUDE report 19938804 ↗
  • InjuryMay 13, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRY VISION. THE PATIENT UNDERWENT SALZMAN'S MODULE IRRIGATION AND CYLINDRICAL NEW SURFACE POST-CORNEAL RESURFACING. ADDITIONAL INFORMATION HAS BEEN RECEIVED AND STATED THAT PATIENT HAD SALZMAN'S MODULE THAT WAS THOUGHT TO BE INSIGNIFICANT BUT PROVED TO GREATLY AFFECT CYLINDER AND SPHERICAL POWER MEASUREMENTS. PATIENT WAS SIGNIFICANTLY OUT OF FOCUS WITH INITIAL LENS IMPLANT CORNEA WAS RESURFACED AND ALLOWED TO HEAL. THE LENS WAS EXPLANTED AND REPLACED WITH COMPANY LENS IN A SECONDARY PROCEDURE.

    Patient problems: Blurred Vision; Visual Impairment

    MAUDE report 19296560 ↗
  • InjuryApr 10, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ADDITIONAL INFORMATION HAS BEEN RECEIVED FROM THE PHYSICIAN AND STATED THAT SYMPTOMS WERE RESOLVED

    Patient problems: Blurred Vision; Endophthalmitis; Toxic Anterior Segment Syndrome (TASS)

    MAUDE report 16708378 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page